Comparative evaluation of taurine and thiotaurine as protectants against diabetes-induced nephropathy in a rat model

Advances in Experimental Medicine and Biology

Volumn 775, Issue , 2013, Pages 371-394

  Pandya, Kashyap G ^a   Budhram, Roshil ^a   Clark, George ^a   Lau Cam, Cesar A ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUTATHIONE; ISOPHANE INSULIN; NITRITE; POTASSIUM ION; SODIUM ION; TAURINE; TAURINE DERIVATIVE; THIOTAURINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GLUTATHIONE DISULFIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MALONALDEHYDE; NITRIC OXIDE; PROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFICACY; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOINSULINEMIA; HYPONATREMIA; HYPOPROTEINEMIA; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEINURIA; RAT; RAT MODEL; RENAL PROTECTION; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT OUTCOME; UREMIA; URINALYSIS; URINE VOLUME; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; KIDNEY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL; URINE; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; CREATININE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLUTATHIONE DISULFIDE; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; KIDNEY; MALE; MALONDIALDEHYDE; NITRIC OXIDE; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TAURINE; TRANSFORMING GROWTH FACTOR BETA1; WEIGHT GAIN;

MLCS; MLOWN;

EID: 84878789876     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-6130-2_29     Document Type: Article

References (77)

1. Acharya M, Lau-Cam CA (2010) Comparison of the protective actions of N-acetylcysteine, hypotaurine and taurine against acetaminophen-induced hepatotoxicity in the rat. J Biomed Sci 17:S35
2. Adler S (2004) Diabetic nephropathy: linking histology, cell biology, and genetics. Kidney Int 66:2095-2106
3. Aruoma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 256:251-255
4. Arya A, Aggarwal S, Yadav HN (2010) Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2:24-29
5. Balakumar P, Chakkarwar VA, Kumar V, Jain A, Reddy J, Singh M (2008) Experimental models for nephropathy. J Renin Angiotensin Aldosterone Syst 9:189-195
6. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbaş U, Aykaç-Toker G, Uysal M (2001) Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 20:251-254
7. Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J (Clin Res Ed) 293:471-474
8. Brøns C, Spohr C, Storgaard H, Dyerberg J, Vaag A (2004) Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur J Clin Nutr 58:1239-1247
9. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302-310
10. Catherwood MA, Powell LA, Anderson P, McMaster D, Sharpe PC, Trimble ER (2002) Glucoseinduced oxidative stress in mesangial cells. Kidney Int 61:599-608
11. Cavallini D, De Marco C, Mondovi B (1960) Enzymatic conversion of cystamine into thiotaurine. Boll Soc Ital Biol Sper 36:1915-1918
12. Cavallinid D, De Marco C, Mondovi B (1959) Chromatographic evidence on the occurrence of thiotaurine in the urine of rats fed with cystine. Biol Chem 234:854-857
13. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK (1997) Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8:1405-1414
14. Das J, Sil PC (2012) Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stressrelated signaling pathways and apoptosis in rats. Amino Acids 43:1509-1523
15. Derlacz RA, Sliwinska M, Piekutowska A, Winiarska K, Drozak J, Bryla J (2007) Melatonin is more effective than taurine and 5-hydroxytryptophan against hyperglycemia-induced kidneycortex tubules injury. J Pineal Res 42:203-209
16. Doerr RC, Fox JB, Lakritz L, Fiddler W (1981) Determination of nitrite in cured meats by chemiluminescence. Anal Chem 53:381-384
17. Egawa M, Kohno Y, Kumano Y (1999) Oxidative effects of cigarette smoke on the human skin. Int J Cosmet Sci 21:83-98
18. Fares J, Kanaan M, Chaaya M, Azar S (2010) Fluctuations in glycosylated hemoglobin (HbA 1c ) as a predictor for the development of diabetic nephropathy in type 1 diabetic patients. Int J Diabetes Mellitus 2:10-14
19. Fellman JH, Green TR, Eicher AL (1987) The oxidation of hypotaurine to taurine: bis-aminoethyla -disulfone, a metabolic intermediate in mammalian tissue. Adv Exp Med Biol 217:39-48
20. Flyvbjerg A (2000) Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 43:1205-1223
21. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R (2002) Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090-3094
22. Franconi F, Di Leo MA, Bennardini F, Ghirlanda G (2004) Is taurine beneficial in reducing risk factors of diabetes? Neurochem Res 29:143-150
23. Goldfarb S, Ziyadeh FN (2001) TGF-b: a crucial component of the pathogenesis of diabetic nephropathy. Trans Am Clin Climatol Assoc 112:27-33
24. Green TR, Fellman JH, Eicher AL, Pratt KL (1991) Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta 1073:91-97
25. Guntherberg H, Rost J (1966) The true oxidized glutathione content of red blood cells obtained by new enzymic and paper chromatographic methods. Anal Biochem 15:205-210
26. Ha H, Kim KH (1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and kinase C. Diabetes Res Clin Pract 45:147-151
27. Ha H, Lee HB (2000) Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58(Suppl 77):S-19-S-25
28. Ha H, Yu MR, Choi YJ, Lee HB (2001) Activation of protein kinase C- d and C- e by oxidative stress in early diabetic rat kidney. Am J Kidney Dis 38:S204-S207
29. Ha H, Yu MR, Kim KH (1999) Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free Radic Biol Med 26:944-950
30. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG (2003) N-Acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285:E744-E753
31. Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 17:330-346
32. Hebden RA, Gardiner SM, Bennett T, MacDonald IA (1986) The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats. Clin Sci (Lond) 70:111-117
33. Higo S, Miyata S, Jiang QY, Kitazawa R, Kitazawa S, Kasuga M (2008) Taurine administration after appearance of proteinuria retards progression of diabetic nephropathy in rats. Kobe J Med Sci 54:E35-E45
34. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74:214-226
35. Huang JS, Chuang LY, Guh JY, Huang YJ, Hsu MS (2007) Antioxidants attenuate high glucoseinduced hypertrophic growth in renal tubular epithelial cells. Am J Physiol 293:F1072-F1082
36. Huang JS, Chuang LY, Guh JY, Yang YL, Hsu MS (2008) Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells. Toxicol Appl Pharmacol 233:220-226
37. Jiang QY (2002) Mechanisms of beneficial effects of taurine on diabetic nephropathy. Med J Kobe Univ 62:119-126
38. Joyner JL, Peyer SM, Lee RW (2003) Possible roles of sulfur-containing amino acids in a chemoautotrophic bacterium-mollusc symbiosis. Biol Bull 205:331-338
39. Kaplan B, Karabay G, Zagyapan RD, Ozer C, Sayan H, Duyar I (2004) Effects of taurine in glucose and taurine administration. Amino Acids 27:327-333
40. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS (2010) Oxidative stress in diabetic nephropathy. Curr Med Chem 17:4256-4269
41. Katsumata M, Kiuchi K, Tashiro T, Uchikuga S (1997) Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues. US Patent Number 5:601,806
42. Kono Y (1998) New raw materials and new technologies for cosmetics. (Part I). Development and its application of "sebum antioxidant thiotaurine" for cosmetics. Fragr J 26:9-14
43. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M (2003) Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14:S250-S253
44. Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835-2838
45. Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB (2005) Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 67:1762-1771
46. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H (2003) Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14:S241-S245
47. Li F, Obrosova IG, Abatan O, Tian D, Larkin D, Stuenkel EL, Stevens MJ (2004) Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288:E29-E36
48. Mathiesen ER, Hommel E, Giese J, Parving HH (1991) Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 303:81-87
49. Miller JA (1999) Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10:1778-1785
50. Monnier L, Colette C (2008) Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials. Expert Opin Pharmacother 9:2857-2865
51. Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T (2004) Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors 20:49-59
52. Nandhini AT, Thirunavukkarasu V, Anuradha CV (2004) Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta Physiol Scand 181:297-303
53. Obrosova IG (2005) Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 7:1543-1552
54. Obrosova IG, Stevens MJ (1999) Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest Ophthalmol Vis Sci 40:680-688
55. Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, Cosso L, Valentini S, Patriarca S, Cottalasso D, Marinari UM, Pronzato MA (2003) Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 52:499-505
56. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R (2007) Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 18:2945-2952
57. Pruski AM, Fiala-Médioni A (2003) Stimulatory effect of sulphide on thiotaurine synthesis in three hydrothermal-vent species from the East Pacific Rise. J Exp Biol 206:2923-2930
58. Reckelhoff JF, Tygart VL, Mitias MM, Walcott JL (1993) STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes 42:1425-1432
59. Ribeiro RA, Bonfleur ML, Amaral AG, Vanzela EC, Rocco SA, Boschero AC, Carneiro EM (2009) Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets. Diabetes Metab Res Rev 25:370-379
60. Rossing K, Christensen PK, Jensen BR, Parving HH (2002a) Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Diabetes Care 25:95-100
61. Rossing P, Hougaard P, Parving HH (2002b) Risk factors for development of incipient and diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25:859-864
62. Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91-99
63. Simşek M, Naziroglu M, Erdinç A (2005) Moderate exercise with a dietary vitamin C and E combination protects against streptozotocin- induced oxidative damage to the kidney and lens in pregnant rats. Exp Clin Endocrinol Diabetes 113:53-59
64. Tada H, Ishii H, Isogai S (1997) Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46:779-784
65. Trachtman H, Futterweit S, Bienkowski R (1993) Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem Biophys Res Commun 191:759-765
66. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH (1995) Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol 269:F429-F438
67. Trachtman H, Futterweit S, Prenner J, Hanon S (1994) Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochem Biophys Res Commun 199:346-352
68. Vaishya R, Singh J, Lal H (2009) Biochemical effects of irbesartan in experimental diabetic nephropathy. Indian J Pharmacol 41:252-254
69. Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, Deferran G (2002) Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 50:443-451
70. Wang LJ, Zhang L, Yu Y, Wang Y, Niu N (2008) The protective effects of taurine against early renal injury in STZ-induced diabetic rats, correlated with inhibition of renal LOX-1-mediated ICAM-1 expression. Ren Fail 30:763-771
71. Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J (2008) Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie 91:261-270
72. Wollenberger A, Ristau O, Schoffa G (1960) Eine einfache Technik der extrem schneller Abkuhlung grosserer Gewebstucke. Pflugers Arch. Gesamte Physiol. Menschen Tiere 270:399-412
73. Yancey PH (2005) Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses. J Exp Biol 208:2819-2830
74. Yancey PH, Ishikawa J, Meyer B, Girguis PR, Lee RW (2009) Thiotaurine and hypotaurine contents in hydrothermal-vent polychaetes without thiotrophic endosymbionts: correlation with sulfide exposure. J Exp Zool A Ecol Genet Physiol 311A:439-447
75. Yao HT, Lin P, Chang YW, Chen CT, Chiang MT, Chang L, Kuo YC, Tsai HT, Yeh TK (2009) Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Food Chem Toxicol 47:1703-1709
76. Yoshiyuki K, Yoshiki M (2000) Peroxidation in the skin and its prevention. Jpn J Inflamm 20:119-129
77. Zheng CM, Ma WY, Wu CC, Lu KC (2012) Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta 413:1555-1561